Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/17/2009WO2009150038A1 Process for the preparation of ezetimibe and composition containing it
12/17/2009WO2009150023A2 Enzymatic synthesis of sphingolipids
12/17/2009WO2009150022A2 Enzymatic synthesis of sphingolipids
12/17/2009WO2009150007A1 Angiotensin ii receptor antagonists
12/17/2009WO2009149955A2 Method for the selection of a suitable adjuvant for the production of solid dispersions for pharmaceutical formulations
12/17/2009WO2009149920A1 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders
12/17/2009WO2009149851A1 New co-crystal compound of rivaroxaban and malonic acid
12/17/2009WO2009149837A1 Substituted 4- (indazolyl) -1,4-dihydropyridines and methods of use thereof
12/17/2009WO2009149836A1 Annellated 4- (indazolyl) -1,4-dihydropyridine derivatives and methods of use thereof
12/17/2009WO2009149820A1 Annelated n-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
12/17/2009WO2009149819A1 Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
12/17/2009WO2009149795A2 Heterocyclic cyclopropyl-substituted fxr binding compounds
12/17/2009WO2009149785A1 Highly active antioxidant based on trehalulose
12/17/2009WO2009149649A1 Aralkyl alcohol piperidine derivative and the use as medicament for treating depression thereof
12/17/2009WO2009149621A1 Use of icariside ii in manufacture of products for preventing or treating male or female sexual dysfunction
12/17/2009WO2009149508A1 Novel potassium channel blockers and uses thereof
12/17/2009WO2009149496A1 Treatment of diabetes and complications thereof and related disorders
12/17/2009WO2009132225A3 Rehydratable polysaccharide particles and sponge
12/17/2009WO2009132093A3 Substituted arylcyclopentenes as therapeutic agents
12/17/2009WO2009131486A3 Photosensitiser and a method for the production thereof
12/17/2009WO2009129798A3 Diphosphate and triphosphate prodrugs, in particular nucleoside diphosphate and triphosphate prodrugs
12/17/2009WO2009129401A8 Kinase inhibitors
12/17/2009WO2009129208A8 Compositions and methods of inducing endoplasmic reticulum stress reponse
12/17/2009WO2009126822A9 Methods of regulating actin cytoskeletal rearrangement and intercellular gap formation
12/17/2009WO2009126315A3 Macrocyclic compounds and methods of treatment
12/17/2009WO2009126274A3 Methods and compositions for the treatment of cancers, such as melanomas and gliomas
12/17/2009WO2009124552A3 Use of a combination of hypothermia inducing drugs
12/17/2009WO2009124266A3 Alkylated semi-synthetic glycosaminoglycosan ethers, and methods for making and using thereof
12/17/2009WO2009119980A3 Benzophenone thiazole derivatives useful for inhibiting formation of microtubule and method for producing the same
12/17/2009WO2009117669A3 Treatment with opioid antagonists and mtor inhibitors
12/17/2009WO2009117410A3 Formation of nanostructured particles of poorly water soluble drugs and recovery by mechanical techniques
12/17/2009WO2009116061A3 Stable oral pharmaceutical composition comprising atorvastatin
12/17/2009WO2009114950A8 Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain
12/17/2009WO2009114740A9 Use of gabaa receptor antagonists for the treatment of excessive sleepiness and disorders associated with excessive sleepiness
12/17/2009WO2009114325A3 Methotrexate adjuvants to reduce toxicity and methods for using the same
12/17/2009WO2009112758A3 Novel use of zinc n-acetyltaurinate
12/17/2009WO2009111516A3 Stabilization of omega-3 fatty acids in oil-water emulsions
12/17/2009WO2009110938A9 Novel macrocyclic polyene lactams
12/17/2009WO2009109867A3 Crystal form of phenylamino pyrimidine derivative
12/17/2009WO2009106714A3 Self-emulsifiable liquid florfenicol composition intended to be incorporated into the drinking water of livestock animals
12/17/2009WO2009106574A3 Combination comprising a cannabinoid receptor binding compound and an opioid
12/17/2009WO2009106361A3 Inhibitors of cell proliferation and uses thereof
12/17/2009WO2009105669A3 Angiogenesis inhibition
12/17/2009WO2009100690A8 Amourphous form of the adamantylamino-platinum ( iv) complexla-12
12/17/2009WO2009091374A3 Fused heterocyclic derivatives and methods of use as c-met inhibitors
12/17/2009WO2009080778A3 Preparations with rosehip extracts, and method of producing rosehip extracts
12/17/2009WO2009074827A3 Combination comprising a mek inhibitor and an aurora kinase inhibitor
12/17/2009WO2009066041A3 Derivatives of 1,2,4,5-tetrahydro-3h-benzazepines, preparation method therefor and pharmaceutical compositions containing same
12/17/2009WO2009062740A9 Use of an ozone/oxygen mixture as primary anticancer therapy through intraperitoneal insufflation
12/17/2009WO2009061491A3 Type iii secretion inhibitors and uses thereof
12/17/2009WO2009058907A3 Targeting micrornas for the treatment of liver cancer
12/17/2009WO2009027644A3 Compositions for the treatment of neoplastic diseases
12/17/2009WO2009010238A3 Duloxetine formulations
12/17/2009WO2008144931A8 Compositions and methods for modulating gated ion channels
12/17/2009WO2008129308A3 Drug combination of beta 2 agonist and a progestin for the treatment of muscle loss
12/17/2009WO2008117229A4 Muscarinic receptor antagonists
12/17/2009WO2008109727A8 Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators
12/17/2009WO2007137156A8 Rnai modulation of aha and therapeutic uses thereof
12/17/2009WO2007131238A8 Compounds and methods for modulating expression apob
12/17/2009US20090312724 Nasal and Ophthalmic Delivery of Aqueous Corticosteroid Solutions
12/17/2009US20090312706 Transdermal local anesthetic patch with injection port
12/17/2009US20090312554 Novel Process for the Preparation of Hexacyclic Compounds
12/17/2009US20090312543 Pyrazole compounds useful as protein kinase inhibitors
12/17/2009US20090312438 Compositions and Methods for Attenuating the Formation of A2E in the Retinal Pigment Epithelium
12/17/2009US20090312437 Anthraquinones and Analogs from Rhuem palmatum for Treatment of Estrogen Receptor Beta-Mediated Conditions
12/17/2009US20090312436 Rasagiline for parkinson's disease modification
12/17/2009US20090312435 Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
12/17/2009US20090312434 Use of 3,5-seco-4-nor-cholestane derivatives for obtaining a cytoprotective drug
12/17/2009US20090312433 Treatment of vr1-antagonist-induced increase in body temperature with an antipyretic agent
12/17/2009US20090312430 Colchicine solid-state forms; methods of making; and methods of use thereof
12/17/2009US20090312429 Administration of nepafenac or derivatives thereof for treating dermatological/keratinization disorders
12/17/2009US20090312427 Medicament for Use in Connection With Cartilage Impairment
12/17/2009US20090312426 Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid
12/17/2009US20090312425 Process for producing 1,4-dihydroxy-2-naphthoic acid
12/17/2009US20090312424 Aromatic prodrugs of propofol, compositions and uses thereof
12/17/2009US20090312423 Therapeutic treatment for lung conditions
12/17/2009US20090312422 Method of modulating cellular activity and agents useful for same
12/17/2009US20090312421 Gel useful for the delivery of cosmetic active ingredients
12/17/2009US20090312419 CREATINE -ßALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE
12/17/2009US20090312417 Platinum(ii) complexes, preparation and use
12/17/2009US20090312416 Treatment of sleep-wake disorders
12/17/2009US20090312415 Remedy/preventive for vascular disorders and hypertension and method of screening the same
12/17/2009US20090312414 Treatment Of Lower Urinary Tract Dysfunction With CB2-Receptor-Selective Agonists
12/17/2009US20090312413 Composition Comprising Tanshinone Compounds Isolated From The Extract Of Salviae Miltiorrhizae Radix For Treating Or Preventing Cognitive Dysfunction And The Use Thereof
12/17/2009US20090312412 3,4-diamino-3-cyclobutene-1,2-dione derivatives as potassium channel openers
12/17/2009US20090312411 Preventing or reducing risk of miscarriages
12/17/2009US20090312410 Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
12/17/2009US20090312409 Lipopexia inhibitor and food or beverage
12/17/2009US20090312408 Isoflavan and isoflavene compounds and their use as angiogenesis inhibitors
12/17/2009US20090312407 Synthetic Flavonoids and Pharmaceutical Compositions and Therapeutic Methods of Treatment of Cancer and other Pathologies
12/17/2009US20090312406 Coumarin compounds and their use for treating viral infection
12/17/2009US20090312405 Methods to Predict and Prevent Resistance to Taxoid Compounds
12/17/2009US20090312404 Cleavable Carnitine Compound
12/17/2009US20090312403 Compositions and methods for wt1 specific immunotherapy
12/17/2009US20090312401 Isolated dna fragment of the sparc human promoter and its use for driving the expression of an heterologous gene in tumor cells
12/17/2009US20090312400 Methods for Therapy of Neurodegenerative Disease of the Brain
12/17/2009US20090312399 Guanosine-rich oligonucleotides as agents for inducing cell death in eukaryotic cells
12/17/2009US20090312398 Compositions and their uses directed to il-4r alpha
12/17/2009US20090312396 Methods for cancer treatment using tak1 inhibitors
12/17/2009US20090312395 Assay
1 ... 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 ... 7860